Podcasts about Moderna

Could studying the DNA of extinct animals – or even bringing them back to life – help us save today's endangered species and inform modern medicine?  That may sound like the premise for a Hollywood movie, but it's work that our Raise the Line guest, Dr. Beth Shapiro, is actually engaged in as Chief Science Officer at Colossal Biosciences, which describes itself as the world's first and only de-extinction company.  “It's not just about learning about the past. It's learning about the past so we have more validated scientific information that we can use to predict what we can do to better influence the future,” she tells host Michael Carrese. An internationally-renowned evolutionary molecular biologist and paleogeneticist, Dr. Shapiro is a pioneer in ancient DNA research and has successfully sequenced genomes, like that of the dodo, to study evolution and the impact on humans. At Colossal Biosciences, she leads teams working to bring back traits of extinct species such as the mammoth, not for spectacle, but to restore ecological balance. “When species become extinct, you lose really fundamental interactions between species that existed in that ecosystem. By taking a species that's alive today and editing its DNA so that it resembles those extinct species, we can functionally replace those missing ecological interactions.” Tune into this utterly fascinating conversation to hear about what Jurassic Park got wrong, the positive ecological impact of reintroducing giant tortoises to Mauritius, and the ethics of using gene editing and other biotechnologies. Mentioned in this episode:Colossal Biosciences If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/podcast

In Folge der Quartalszahlen geht es bei den Aktien von Snap, Moderna, Figma, ARM und Albermarle teils deutlich bergauf. Wir sehen hingegen massive Kurseinbrüche bei Duolingo, DoorDash, Elf Beauty und Fortinet. Medienberichten zur Folge hat Softbank zu Beginn des Jahres eine Übernahme von Marvell in Erwägung gezogen. Die beiden Parteien konnten sich nicht einigen. Wie dem auch sei, geht es wegen dieser Berichte bei dem Wert aufwärts. Nach dem Closing werden die Ergebnisse von Airbnb, Affirm und Block im Fokus stehen. Außerdem beginnt um 22 Uhr MEZ die Hauptversammlung von Tesla. Marktteilnehmer gehen davon aus, dass trotz des Widerstands einiger Aktionäre, das $1 Bio. Zahlungspaket an Musk genehmigt wird. Was den Regierungs-Shutdown betrifft, sehen wir ab diesen Freitag bei 40 Flughäfen eine Reduktion der Flüge um 10%. Immer mehr Fluglotsen bleiben wegen der Gehaltsausfälle zu Hause. Abonniere den Podcast, um keine Folge zu verpassen! ____ Folge uns, um auf dem Laufenden zu bleiben: • X: http://fal.cn/SQtwitter • LinkedIn: http://fal.cn/SQlinkedin • Instagram: http://fal.cn/SQInstagram

Der Grundton an der Wall Street ist positiv, wobei das Bild zerrissen bleibt. In Folge der Quartalszahlen geht es bei den Aktien von Snap, Moderna, Figma, ARM und Albermarle teils deutlich bergauf. Wir sehen hingegen massive Kurseinbrüche bei Duolingo, DoorDash, Elf Beauty und Fortinet. Medienberichten zur Folge hat Softbank zu Beginn des Jahres eine Übernahme von Marvell in Erwägung gezogen. Die beiden Parteien konnten sich nicht einigen. Wie dem auch sei, geht es wegen dieser Berichte bei dem Wert aufwärts. Nach dem Closing werden die Ergebnisse von Airbnb, Affirm und Block im Fokus stehen. Außerdem beginnt um 22 Uhr MEZ die Hauptversammlung von Tesla. Marktteilnehmer gehen davon aus, dass trotz des Widerstands einiger Aktionäre, das $1 Bio. Zahlungspaket an Musk genehmigt wird. Was den Regierungs-Shutdown betrifft, sehen wir ab diesen Freitag bei 40 Flughäfen eine Reduktion der Flüge um 10%. Immer mehr Fluglotsen bleiben wegen der Gehaltsausfälle Zuhause. Ein Podcast - featured by Handelsblatt. +++ Alle Rabattcodes und Infos zu unseren Werbepartnern findet ihr hier: https://linktr.ee/wallstreet_podcast +++ +++ Hinweis zur Werbeplatzierung von Meta: https://backend.ad-alliance.de/fileadmin/Transparency_Notice/Meta_DMAJ_TTPA_Transparency_Notice_-_Ad_Alliance_approved.pdf +++ Der Podcast wird vermarktet durch die Ad Alliance. Die allgemeinen Datenschutzrichtlinien der Ad Alliance finden Sie unter https://datenschutz.ad-alliance.de/podcast.html Die Ad Alliance verarbeitet im Zusammenhang mit dem Angebot die Podcasts-Daten. Wenn Sie der automatischen Übermittlung der Daten widersprechen wollen, klicken Sie hier: https://datenschutz.ad-alliance.de/podcast.html Impressum: https://www.360wallstreet.de/impressum

Le prime pagine dei principali quotidiani nazionali commentate in rassegna stampa da Davide Giacalone. L'accordo sul taglio flessibile delle emissioni e la delocalizzazione delle imprese, gli aumenti dei salari, l'arresto di Almasri a Tripoli, Zohran Mamdani il nuovo sindaco di New York. Spazio Donna Moderna dedicato agli incubi, quelli che a volte possono farci trascorrere notti agitate. Ma le neuroscienze, ci raccontano che i brutti sogni hanno spesso una funzione positiva. Ne abbiamo parlato con Donatella Gianforma, di Donna Moderna. Torniamo a parlare dell'impegno delle italiane nelle Coppe internazionali con i nostri inviati sui campi: Paolo Pacchioni, Andrea Salvati e Nicolò Pompei. Don Antonio Mazzi, fondatore della comunità Exodus, regala ogni giorno un pensiero, un suggerimento, una frase agli ascoltatori di RTL 102.5. L'accoltellamento avvenuto a Milano, in Piazza Gae Aulenti. L'uomo arrestato, un soggetto psicologicamente instabile, era stato già autore di un'aggressione simile tempo fa, era finito in una comunità dopo una condanna e, nonostante questo, è tornato a commettere un gesto di violenza. Com'è stato possibile? Come funziona la gestione di questi soggetti? Secondo il ministro Piantedosi, dopo la chiusura dei manicomi e l'attuale sistema servirebbe una "terza via". Ne abbiamo parlato con il professor Massimo Clerici, ordinario di Psichiatria all'Università degli studi di Milano Bicocca e direttore del dipartimento di Salute mentale dell'ospedale San Gerardo di Monza. Da alcuni giorni ci giungono notizie dal Nepal di alpinisti italiani, ma non solo, che hanno perso la vita o che non risultano rintracciabili da molte ore. Diverse le spedizioni coinvolte. Proprio ieri Reinhold Messner, l'alpinista degli 8mila e grande esperto di Nepal, è intervenuto su quanto accaduto. Sostiene che «Il rispetto per la montagna è diminuito, oggi in agenzia compri un biglietto per l'Everest. Io ho rinunciato alla metà delle mie ascese perché era troppo pericoloso". Ne abbiamo parlato con il Presidente del CAI, il Club Alpino Italiano, Antonio Montani. L'attualità, commentata dal presidente di regione Lombardia, Attilio Fontana. All'interno di Non Stop News, con Massimo Lo Nigro, Enrico Galletti e Giusi Legrenzi.

DITCH YOUR DOCTOR! https://www.livelongerformula.com/wam Get a natural health practitioner and work with Christian Yordanov! Mention WAM and get a FREE masterclass! You will ALSO get a FREE metabolic function assessment! GET YOUR APRICOT SEEDS at the life-saving Richardson Nutritional Center HERE: https://rncstore.com/r?id=bg8qc1 Use code JOSH to save money! Get Your SUPER-SUPPLIMENTS HERE: https://vni.life/wam Use Code WAM15 & Save 15%! Life changing formulas you can't find anywhere else! GET YOUR WAV WATCH HERE: https://buy.wavwatch.com/WAM Use Code WAM to save $100 and purchase amazing healing frequency technology! Josh Sigurdson reports on the manufactured cancer crisis as the FDA recalls over half a million bottles of blood pressure pills contaminated with cancer causing chemicals. The pills under the brand names Minipress and Prazin contained nitrosamine impurities risking 580,000 people. This "contamination" seems to happen all the time. Remember the Johnson&Johnson cover-up regarding baby powder which only came out after a massive lawsuit. It was exposed that J&J KNEW the baby powder caused cancer. Then there is SV40 found in many childhood vaccines as well as the confirmation by Moderna that the mRNA covid injections caused cancer. A cancer causing drug which has been banned in almost every country on earth continues to be allowed in pork within the United States. Carbadox is a drug given to pigs which is incredibly carcinogenic, yet here we are. Despite the United States government being fully aware of the dangers, it continues to be used in pork on a mass scale with no way to actually track which pork has it and which pork doesn't. While the FDA claims to be cracking down on unapproved fluoride supplements for children, they ignore the health crisis that is fluoride (hydrofluocilisic acid) in the tap water, poisoning people through both drinking and showering in the water. The FDA is also fast tracking self amplifying mRNA for Bird Flu and approved 10 new kids of mRNA vaccines for children ages 6 months to 10 years old. How is this a so-called "rebellious FDA?" This is a worldwide problem. NHS hospitals are purposely serving cancer causing foods right next to oncology departments. There is a concerted effort to make people sick and weak in order to be more easily controlled as well as more easily lead into a technocratic digital ID based hell. Currently, the US government is funding 500 million dollars towards an AI agenda which includes Larry Ellison's mRNA cancer vaccine push. This is not a solution and makes a bad problem worse. There are real world solutions out there for cancer but we aren't allowed to talk about them without risking prison time despite countless world renowned scientists backing the solutions, not to mention millions of testimonies. Stay tuned for more from WAM! HELP SUPPORT US AS WE DOCUMENT HISTORY HERE: https://gogetfunding.com/help-keep-wam-alive/# GET HEIRLOOM SEEDS & NON GMO SURVIVAL FOOD HERE: https://heavensharvest.com/ USE Code WAM to save 5% plus free shipping! BUY GOLD HERE: https://firstnationalbullion.com/schedule-consult/ FIND OUR CoinTree page here: https://cointr.ee/joshsigurdson PURCHASE MERECHANDISE HERE: https://world-alternative-media.creator-spring.com/ PayPal: ancientwonderstelevision@gmail.com JOIN US on SubscribeStar here: https://www.subscribestar.com/world-alternative-media For subscriber only content! Pledge here! Just a dollar a month can help us alive! https://www.patreon.com/user?u=2652072&ty=h&u=2652072 BITCOIN ADDRESS: 18d1WEnYYhBRgZVbeyLr6UfiJhrQygcgNU World Alternative Media 2025

According to the Bloomberg School of Public Health at Johns Hopkins University, women make up 70% of the global healthcare workforce but hold only about 25% of leadership positions. Our guest today on Raise the Line, Dr. Roopa Dhatt, has been a leading voice in the movement to correct that imbalance through co-founding an organization called Women in Global Health (WGH), which has established chapters in over 60 countries since it started a decade ago. Dr. Dhatt is also pursuing that agenda and addressing other pressing issues in healthcare as a Young Global Leader at the World Economic Forum. “We're changing the equation so women delivering health are also viewed and valued as leaders,” says the internal medicine physician and assistant professor at Georgetown University School of Medicine. Beyond leadership equity, Dr. Dhatt is also seeking to address systemic pay inequities and high levels of violence and harassment experienced by women in the health sector, issues that were highlighted in research conducted by WGH. Although WGH has seen high-level success influencing policy at the World Health Organization and United Nations, Dr. Dhatt says the heart of its success is local. “Women community health workers have begun to see themselves as leaders and the heroines of health in their communities. That's profound change.” Join host Michael Carrese for a probing conversation that identifies the structural barriers blocking advancement for women and that explains why the health of communities and the planet depend on inclusive leadership.Mentioned in this episode:Women in Global HealthWHO Report: Delivered By Women, Led By MenDr. Roopa Dhatt on LinkedIn If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/podcast

Franz Kafka escribió Carta al padre en 1919, pero nunca se la entregó. En esas páginas, una de las confesiones más intensas de la literatura moderna, le habla a un padre autoritario, omnipresente y temido. Le habla también al miedo, a la culpa y a la herida que define toda su obra. En este episodio exploramos qué hay detrás de esa carta: la estructura psicológica de Kafka, la figura paterna como símbolo de poder, y cómo el trauma personal se convierte en una forma de escritura. ¿Es posible escribir para liberarse de un padre? ¿O la literatura solo repite la herida? Un análisis entre la biografía, la filosofía y la psicología literaria de una de las cartas más brutales y reveladoras del siglo XX.

Esta semana falamos do imposto do papel selado, criado em 1660 e que resistiu até 1986, e da mítica Padeira de Aljubarrota.Sugestões da semana1. Documentário: Os 100 Dias que Marcaram a História Moderna (2022), disponível na RTP Play: https://www.rtp.pt/play/p15619/os-100-dias-que-marcaram-a-historia-moderna2. Jean Lopez (dir) - Atlas da II Guerra Mundial. Guerra e Paz, 2025.----Obrigado aos patronos do podcast:André Silva, Bruno Figueira, Cláudio Batista, Gustavo Fonseca, Isabel Yglesias de Oliveira, Joana Figueira, Manuel Prates, Miguel Vidal, NBisme, Oliver Doerfler;Alessandro Averchi, Alexandre Carvalho, Andre Oliveira, Carla Pinelas, Carlos Castro, Civiforum, Lda., Cláudia Conceição, Daniel Murta, Domingos Ferreira, É Manel, Francisco, Hugo Picciochi, João Cancela, João Carreiro, João Pedro Tuna Moura Guedes, Jorge Filipe, José Beleza, Luís André Agostinho, Patrícia Gomes, Pedro Almada, Pedro Alves, Pedro Ferreira, Rui Roque, Tiago Pereira, Vera Costa; Adriana Vazão, Ana Gonçalves, Ana Sofia Agostinho, André Abrantes, Andre de Oliveira, André Silva, António Farelo, António J. R. Neto, António Silva , Bruno Luis, Carlos Afonso, Carlos Ribeiro, Carlos Ribeiro, Catarina Ferreira, Diogo Freitas, Eugenia Capela, Fábio Videira Santos, Francisco Fernandes, Gn, Gonçalo Pedro, Hugo Palma, Hugo Vieira, Igor Silva, João Barbosa, João Canto, João Carlos Braga Simões, João Diamantino, João Félix, João Ferreira, Joao Godinho, João Pedro Mourão, Joel José Ginga, Johnniedee, José Santos, Mafalda Trindade, Miguel Brito, Miguel Gama, Miguel Gonçalves Tomé, Miguel Oliveira, Miguel Salgado, Nuno Carvalho, Nuno Esteves, Nuno Moreira, Nuno Silva, Parte Cóccix, Paulo Ruivo, Paulo Silva, Pedro, Pedro Cardoso, Pedro Oliveira, Pedro Simões, Ricardo Pinho, Ricardo Santos, Rodrigo Candeias, Rui Curado Silva, Rui Rodrigues, Simão, Simão Ribeiro, Sofia Silva, Thomas Ferreira, Tiago Matias, Tiago Sequeira, Tomás Matos Pires, Vitor Couto.-----Ouve e gosta do podcast?Se quiser apoiar o Falando de História, contribuindo para a sua manutenção, pode fazê-lo via Patreon: https://patreon.com/falandodehistoria-----Música: "Hidden Agenda” de Kevin MacLeod (incompetech.com); Licensed under Creative Commons: By Attribution 4.0 License, http://creativecommons.org/licenses/by/4.0Edição de Marco António.

Amazon bekommt einen $38 Mrd. Auftrag von OpenAi, was den Nadsaq anfacht. Ansonsten ist die Tendenz trotz eines Mega-Deal im Pharmabereich und einer weiteren Annäherung zwischen China und den USA uneinheitlich. Kenvue wird für fast $50 Mrd. von Kimberly Clark übernommen. Letzte Woche kursierten Gerüchte, dass sich auch Moderna zum Verkauf aufgestellt hat. Die Aktionäre werden in Cash und Aktien angefunden. Was Quartalszahlen betrifft, hatte wir letzte Woche den Zenit der Meldungen. Es haben nicht nur ungewöhnlich viele Unternehmen die Ertragsziele geschlagen. 43% der Firmen, die sich zu den Aussichten äußerten, haben die Prognosen angehoben. Wir sehen für Q3 nun ein solides Gewinnwachstum von 10,7%, berichtet FactSet. Berkshire Hathaway konnte am Wochenende die Erwartungen ebenfalls übertreffen, mit der Aktie vor dem Opening freundlich. Im weiteren Wochenverlauf stehen erneut einige wichtige Tech-Ergebnisse an. Heute Abend meldet Palantir, gefolgt von AMD, Arista Networks, Super Micro, Shopify und Spotify am Dienstag. Abonniere den Podcast, um keine Folge zu verpassen! ____ Folge uns, um auf dem Laufenden zu bleiben: • X: http://fal.cn/SQtwitter • LinkedIn: http://fal.cn/SQlinkedin • Instagram: http://fal.cn/SQInstagram

Ein Paukenschlag im Pharmasektor treibt die Börse zum Wochenstart an: Kimberly Clark übernimmt Kenvue für fast 50 Milliarden Dollar! Auch aus China und den USA gibt es versöhnliche Töne – ein weiteres Signal für Entspannung zwischen den Supermächten. Gerüchte um Moderna machen weiter die Runde: Steht auch hier ein Verkauf bevor? Währenddessen zeigt sich die Berichtssaison von ihrer starken Seite – 43% der Unternehmen haben ihre Prognosen angehoben, und laut FactSet liegt das Gewinnwachstum im dritten Quartal bei soliden 10,7%. Berkshire Hathaway glänzt mit besser als erwarteten Zahlen, die Aktie startet freundlich in die Woche. Und es bleibt spannend: Palantir meldet heute Abend, AMD, Arista Networks, Super Micro, Shopify und Spotify folgen am Dienstag. Ein Podcast - featured by Handelsblatt. +++ Alle Rabattcodes und Infos zu unseren Werbepartnern findet ihr hier: https://linktr.ee/wallstreet_podcast +++ +++ Hinweis zur Werbeplatzierung von Meta: https://backend.ad-alliance.de/fileadmin/Transparency_Notice/Meta_DMAJ_TTPA_Transparency_Notice_-_Ad_Alliance_approved.pdf +++ Der Podcast wird vermarktet durch die Ad Alliance. Die allgemeinen Datenschutzrichtlinien der Ad Alliance finden Sie unter https://datenschutz.ad-alliance.de/podcast.html Die Ad Alliance verarbeitet im Zusammenhang mit dem Angebot die Podcasts-Daten. Wenn Sie der automatischen Übermittlung der Daten widersprechen wollen, klicken Sie hier: https://datenschutz.ad-alliance.de/podcast.html Impressum: https://www.360wallstreet.de/impressum

→il mio nuovo corso sugli infortuni in palestra: https://www.calabrettosimone.it/corso-infortuni-in-palestra-online/ → il mio libro “powerlifting dalla teoria alla pratica”: https://amzn.eu/d/6QK8B62 → Visita il mio sito: https://www.calabrettosimone.it/ → Leggi tutti gli articoli gratuiti nel mio blog: https://www.calabrettosimone.it/blog/ → Info su coaching online, consulenze dal vivo e online, programmi di allenamento personalizzati, info sul corso “imparare a programmare l'allenamento della […]

Neste episódio, recebemos o cientista de dados Paulo da Silva para uma conversa rica sobre os desafios e práticas do ML Ops no cotidiano profissional. Ele também compartilhou uma visão abrangente sobre os conceitos de DevOps e DataOps, destacando suas interseções com o mundo da ciência de dados.

Fala, pirataria! Está no mar o nosso novo podcast! Neste episódio, Daniel Gomes de Carvalho (@danielgomesdecr) recebe André Sekkel (UNIFESP) para uma discussão sobre os emblemas na Época Moderna. Canal do História Pirata no YouTube: www.youtube.com/@historiapirata chave pix: podcast.historiapirata@gmail.com Livro do Prof. Daniel sobre a Revolução Francesa: www.editoracontexto.com.br/produto/rev…esa/5105603 Livro sobre Thomas Paine e a Revolução Francesa, download gratuito: www.academia.edu/127250233/Thomas…mes_de_Carvalho_ Esse episódio foi editado por: Gabriel Campos (@_grcampos)

Te invitamos a escucharnos todos los viernes en punto de las 18:00hrs. En compañía de Jorge Escamilla H. presentando su programa La sociedad Moderna- Terapias complementarias bienestar integral Compártenos tus comentarios y síguenos en nuestras redes sociales. Proyecto Radio MX, con Sentido Social

“They say it takes a village to raise a child. I really think it takes a village to treat a patient,” says Dr. Lanae Mullane, a naturopathic doctor and clinical strategist who has spent years at the forefront of bridging functional medicine, nutraceutical development, and digital health. In this episode of Raise the Line, host Lindsey Smith explores Dr. Mullane's view that naturopathic medicine complements conventional care by expanding -- not replacing -- the clinical toolkit, and that collaboration should be the future of medicine. “At the end of the day, collaboration and connection create the best outcomes for the people we serve,” she says. Their in-depth conversation also spans the shifting landscape of women's hormone health, including the perimenopausal transition and long-overdue calls for research equity. “We're not just smaller versions of men. We need to have dedicated research for us.” Tune in to learn about the importance of grounding health in sustainable habits, rethinking midlife care for women, and how to help patients take ownership of their health.Mentioned in this episode:Joi + BlokesSuppCoDr. Mullane's Clinical Website If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/podcast

Como se describió en una investigación prusiana anterior, la Universidad de Marburg, con sede en Prusia, se consideraba su escuela hermana marxista en Alemania.

Neste episódio do Infracast, Fernando Marcato e Isadora Cohen exploram o período que marcou a virada do saneamento brasileiro: o marco legal de 2007 (Lei 11.445).Fernando retoma o contexto do início dos anos 2000, após a saída das empresas estrangeiras e o amadurecimento dos grupos nacionais, como Odebrecht, OAS, Carioca Engenharia e Galvão Engenharia, que passaram de grandes construtoras a operadoras de concessões.A conversa destaca como a Lei 11.445/2007 trouxe previsibilidade e formalidade às relações entre estados e municípios, obrigando a existência de contratos com metas, revisões tarifárias e regulação independente. Essa estrutura inaugurou a cultura da regulação no saneamento, até então inexistente, e incentivou o surgimento das primeiras agências reguladoras estaduais.Fernando explica que, pela primeira vez, o debate não era mais “público ou privado”, mas sim sobre ter um arcabouço regulatório sólido que garantisse segurança jurídica e qualidade na prestação do serviço. Ele mostra como o setor privado também se tornou um agente impulsionador dessa mudança, pressionando pela criação de regras estáveis e contratos claros.Um episódio fundamental para entender como o marco de 2007 estruturou o setor, introduziu a regulação moderna e abriu caminho para o avanço das concessões e PPPs que hoje definem o saneamento no Brasil.Fique por aqui e acompanhe esta série que está puro ouro de conhecimento histórico.Somos o primeiro podcast brasileiro voltado exclusivamente para temas relacionados à infraestrutura.#utilidadepublica #infraestrutura #saneamento #historiadobrasil

Hoje vamos esclarecer o pronunciamento da OMS, sobre como a ingestão descontrolada de medicamentos antibióticos, pode reduzir eficiência da medicina ao combate de novas doenças.See omnystudio.com/listener for privacy information.

Descubre todas las funciones del cabezal termostático Zigbee Moes ZTRV-ZX-TV02-EN, compatible con un hub de Tuya, Jeedom y Home Assistant.Descubre más contenido sobre domótica y sus beneficios en ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠pluyu.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠.

“It's kind of a miracle, frankly,” says Dr. John Buse, a distinguished professor at the University of North Carolina School of Medicine, referring to the effectiveness of GLP-1 receptor agonist medications such as Ozempic in treating type 2 diabetes, promoting significant weight loss, and reducing cardiovascular risk. As a physician scientist for the last three decades at UNC, Dr. Buse has played a key role in ushering in this new era of diabetes care, leading or participating in over 200 clinical studies on this class of drugs and others. “Nothing has impacted diabetes care like the GLP-1 receptor agonists. I have lots of patients whose diabetes was never well controlled who have seen all their metabolic problems essentially resolved.”  In this fascinating conversation with Raise the Line host Lindsey Smith, Dr. Buse not only explains how these drugs work, but also provides a clear-eyed look at side effects, and addresses issues of cost and access. Join us for the remarkable story – including the role played by Gila monsters -- behind one of the biggest developments in medicine over the past several years from a world renowned diabetes researcher and clinician. Mentioned in this episode:UNC School of Medicine If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/podcast

DITCH YOUR DOCTOR! https://www.livelongerformula.com/wam Get a natural health practitioner and work with Christian Yordanov! Mention WAM and get a FREE masterclass! You will ALSO get a FREE metabolic function assessment! GET YOUR APRICOT SEEDS at the life-saving Richardson Nutritional Center HERE: https://rncstore.com/r?id=bg8qc1 Use code JOSH to save money! Get Your SUPER-SUPPLIMENTS HERE: https://vni.life/wam Use Code WAM15 & Save 15%! Life changing formulas you can't find anywhere else! GET YOUR WAV WATCH HERE: https://buy.wavwatch.com/WAM Use Code WAM to save $100 and purchase amazing healing frequency technology! Josh Sigurdson reports on the news of Florida Governor Ron DeSantis attacking the agenda to purposely engineer meat allergies in order to "save the planet" as shills and bioethicists from the World Economic Forum and WHO call for mandates. People like Matthew Liao have been calling for this agenda to be rolled out for years which DeSantis calls insane. However, there is a real world risk of this under a digital food ration system. Recent papers by Western Michigan University have called for this life threatening biowarfare. This is happening as we see 73 year record cattle shortages and the introduction of new imports of beef from Argentina. This is happening as food rations are approved under emergency orders. This is happening as governments and scientific organizations calls for mRNA meat on grocery shelves which is already a thing with pork going back to 2018. Also, traces have been found in other foods. This is happening as Flagship Pioneering alongside Moderna is introducing mRNA pesticides to spray crops. This is happening as scientists in Australia and New Zealand use genetic engineering and "viruses" to make rodents infertile for "pest control." The overall agenda is clearly to make humans infertile without them even knowing it which they're alreading doing. Meanwhile, Texas is suing the Tylenol makers for omitting evidence tying Tylenol to autism, though this is also avoiding the obvious elephant in the room... Vaccines. We are being poisoned like bugs. From fluoride to vaccines. From aerosols to glyphosate. From processed foods to medications. From plastics to purposely tainted meat. The agenda is clear. There is no such thing as TOTAL avoidance but there are real solutions available to prolong life and health in the face of these problems. Stay tuned for more from WAM! HELP SUPPORT US AS WE DOCUMENT HISTORY HERE: https://gogetfunding.com/help-keep-wam-alive/# GET HEIRLOOM SEEDS & NON GMO SURVIVAL FOOD HERE: https://heavensharvest.com/ USE Code WAM to save 5% plus free shipping! BUY GOLD HERE: https://firstnationalbullion.com/schedule-consult/ FIND OUR CoinTree page here: https://cointr.ee/joshsigurdson PURCHASE MERECHANDISE HERE: https://world-alternative-media.creator-spring.com/ PayPal: ancientwonderstelevision@gmail.com JOIN US on SubscribeStar here: https://www.subscribestar.com/world-alternative-media For subscriber only content! Pledge here! Just a dollar a month can help us alive! https://www.patreon.com/user?u=2652072&ty=h&u=2652072 BITCOIN ADDRESS: 18d1WEnYYhBRgZVbeyLr6UfiJhrQygcgNU World Alternative Media 2025

Mayra continúa entrevistando a Ángel sobre su premio MacArthur. En este episodio, hablan sobre la investigación en meteorología tropical moderna que llevó a galardón. Hablamos de historia, ideas modernas, fenómenos, y comparación con las latitudes medias. 

Cap

GET YOUR APRICOT SEEDS at the life-saving Richardson Nutritional Center HERE: https://rncstore.com/r?id=bg8qc1 Use code JOSH to save money! HELP SUPPORT US AS WE DOCUMENT HISTORY HERE: https://gogetfunding.com/help-keep-wam-alive/# Josh Sigurdson talks with John Richardson about the insane increases in cancer across the board including 65% of cancer cases having received one or more covid injections. Moderna has also confirmed that their injections cause cancer. Not only do the vaccines causes a high rate of cancer but we are surrounded by countless cancer causing chemicals and it's clearly by design. Countless doctors have come out and exposed the dangers as well as talked about apricot seeds (laetrile, amygdalin) as a potential solution. In fact, Dr. Dean Burk, the founder of the National Cancer Institute who worked there for 37 years claimed that laetrile was the most successful of every cancer prevention technique they tried. Millions of people agree. It has also been pointed out that Turbo Cancers have an even higher likelihood of being mitigated or even possibly cured by laetrile. For decades, the medical establishment has attempted to censor studies and hide the benefits of apricot seeds. Now, something big is happening. More and more experts are speaking out on the benefits. In this video, John goes over the growing number of doctors, studies and testimonies regarding laetrile and why people should consider at least stocking up on apricot seeds and trying it for themselves. There is no reason to sit on our hands when many of the deadliest illnesses can be prevented. Stay tuned for more from WAM! GET HEIRLOOM SEEDS & NON GMO SURVIVAL FOOD HERE: https://heavensharvest.com/ USE Code WAM to save 5% plus free shipping! BUY GOLD HERE: https://firstnationalbullion.com/schedule-consult/ Avoid CBDCs! GET YOUR WAV WATCH HERE: https://buy.wavwatch.com/WAM Use Code WAM to save $100 and purchase amazing healing frequency technology! Get Your SUPER-SUPPLIMENTS HERE: https://vni.life/wam Use Code WAM15 & Save 15%! Life changing formulas you can't find anywhere else! Get local, healthy, pasture raised meat delivered to your door here: https://wildpastures.com/promos/save-20-for-life/bonus15?oid=6&affid=321 USE THE LINK & get 20% off for life and $15 off your first box! DITCH YOUR DOCTOR! https://www.livelongerformula.com/wam Get a natural health practitioner and work with Christian Yordanov! Mention WAM and get a FREE masterclass! You will ALSO get a FREE metabolic function assessment! SIGN UP FOR HOMESTEADING COURSES NOW: https://freedomfarmers.com/link/17150/ Get Prepared & Start The Move Towards Real Independence With Curtis Stone's Courses! GET YOUR FREEDOM KELLY KETTLE KIT HERE: https://patriotprepared.com/shop/freedom-kettle/ Use Code WAM and enjoy many solutions for the outdoors in the face of the impending reset! PayPal: ancientwonderstelevision@gmail.com FIND OUR CoinTree page here: https://cointr.ee/joshsigurdson PURCHASE MERECHANDISE HERE: https://world-alternative-media.creator-spring.com/ JOIN US on SubscribeStar here: https://www.subscribestar.com/world-alternative-media For subscriber only content! Pledge here! Just a dollar a month can help us alive! https://www.patreon.com/user?u=2652072&ty=h&u=2652072 BITCOIN ADDRESS: 18d1WEnYYhBRgZVbeyLr6UfiJhrQygcgNU World Alternative Media 2025

Os Sociais Democratas defendem mudanças rápidas, mas PS considera pontos da lei inconcebíveis e Chega pede uma lei mais robusta que a proposta de alteração do PSD. See omnystudio.com/listener for privacy information.

In der heutigen Folge sprechen die Finanzjournalistinnen Anja Ettel und Lea Oetjen über den Aktientausch zweier einstiger Biotech-Rivalen, die Begnadigung des reichsten US-Häftlings und den Government Shutdown, der zum Risiko für die Amerikaner wird. Außerdem geht es um SAP, Tesla, Chevron, Exxon, Siemens Energy, Deutsche Telekom, T-Mobile, MTU, Beiersdorf, Unilever, Roche, Atoss, Lukoil, Rosneft, Rivian, Biontech, Curevac, Moderna, Bristol Myers Squibb, BlackRock, Solana, Gold, Bitcoin, Ethereum. Wir freuen uns über Feedback an aaa@welt.de. Noch mehr "Alles auf Aktien" findet Ihr bei WELTplus und Apple Podcasts – inklusive aller Artikel der Hosts und AAA-Newsletter.[ Hier bei WELT.](https://www.welt.de/podcasts/alles-auf-aktien/plus247399208/Boersen-Podcast-AAA-Bonus-Folgen-Jede-Woche-noch-mehr-Antworten-auf-Eure-Boersen-Fragen.html.) [Hier] (https://open.spotify.com/playlist/6zxjyJpTMunyYCY6F7vHK1?si=8f6cTnkEQnmSrlMU8Vo6uQ) findest Du die Samstagsfolgen Klassiker-Playlist auf Spotify! Disclaimer: Die im Podcast besprochenen Aktien und Fonds stellen keine spezifischen Kauf- oder Anlage-Empfehlungen dar. Die Moderatoren und der Verlag haften nicht für etwaige Verluste, die aufgrund der Umsetzung der Gedanken oder Ideen entstehen. Hörtipps: Für alle, die noch mehr wissen wollen: Holger Zschäpitz können Sie jede Woche im Finanz- und Wirtschaftspodcast "Deffner&Zschäpitz" hören. +++ Werbung +++ Du möchtest mehr über unsere Werbepartner erfahren? [**Hier findest du alle Infos & Rabatte!**](https://linktr.ee/alles_auf_aktien) Impressum: https://www.welt.de/services/article7893735/Impressum.html Datenschutz: https://www.welt.de/services/article157550705/Datenschutzerklaerung-WELT-DIGITAL.html

Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we're diving deep into a series of significant events that are shaping the future of drug development and patient care.Starting with Merck KGaA, their decision to close the Active Pharmaceutical Ingredient plant in Arklow, Ireland by 2028 marks a pivotal shift in their manufacturing strategy. This move follows a strategic review and is emblematic of broader industry trends where companies reassess their operational strategies for greater efficiency. While this decision may impact the local workforce and supply chain dynamics, it underscores a wider reevaluation within the industry regarding sourcing strategies and optimizing production capabilities.Turning to regulatory news, Amgen and AstraZeneca have achieved a notable milestone with Tezspire, which has received approval for a second indication in both the U.S. and Europe. This success highlights the strategic importance of expanding drug indications to maximize therapeutic potential and market reach. The approval also reflects a trend where robust clinical data supports regulatory endorsements across various regions, enhancing the global footprint of pharmaceutical innovations.In manufacturing developments, Galderma is making headlines with a $650 million investment in U.S.-based production facilities for Nemluvio. This commitment to domestic manufacturing aligns with industry-wide movements towards reshoring production to bolster supply chain resilience. As demand for dermatological products increases, enhancing local infrastructure promises not only to meet market needs but also to secure supply stability in uncertain times.Meanwhile, Moderna's recent decision to discontinue its congenital cytomegalovirus vaccine program after disappointing Phase 3 results illustrates the inherent uncertainties present in vaccine development. Despite extensive efforts, the vaccine did not demonstrate sufficient efficacy in preventing CMV infections among women. This outcome serves as a reminder of the critical role that robust clinical trial data plays in guiding strategic decisions within pharmaceutical pipelines. While mRNA technology has seen success against COVID-19, this setback highlights complexities involved when tackling other viral pathogens, potentially redirecting Moderna's focus towards more promising candidates.Roche is navigating through challenges such as currency fluctuations and slower-than-expected pharmaceutical sales in its third quarter. Despite these headwinds, Roche projects confidence in its long-term growth strategies, showcasing resilience through its diversified portfolio. Furthermore, Roche's decision to discontinue five Chugai solid tumor assets reflects broader industry movements towards reassessment and realignment within pipelines. Such decisions often emerge from early-phase trials failing to meet expected outcomes or shifts towards areas with greater promise, enabling companies like Roche to streamline resources towards more viable therapeutic areas.Compliance remains under scrutiny at Nephron Pharmaceuticals as ongoing FDA issues emphasize the necessity of maintaining stringent quality standards throughout manufacturing processes. Such regulatory challenges highlight the criticality of ensuring product safety and efficacy within the industry.On the technological front, the integration of artificial intelligence into life sciences commercialization is transforming industry landscapes. Though many organizations are still catching up with this digital shift, those that have embraced AI are experiencing significant improvements in efficiency and patient engagement. As companies continue embedding AI into their strategic frameworks, these initiatives promise to redefine operational paradigms and open new paths for growth.The landscape remains dynaSupport the show

On this week's episode, Chris Garabedian, Brian Skorney, and Sam Fazeli open with optimism about the biotech market, predicting an upcoming acceleration in IPO activity. In deals and financing news, the co-hosts discussed Summit Therapeutics' $500 million raise, with more than half coming from insiders, and continued momentum in M&A, including Alkermes' $2.1 billion acquisition of Avadel for its narcolepsy drug. The group also highlighted Takeda's $1.2 billion oncology deal with Innovent. European biotech funding showed positive signs, evidenced by Tubulis' $360 million Series C. Next, the co-hosts recapped ESMO, spotlighting Summit and Akeso's NSCLC data, Incyte's KRAS G12D inhibitor, and Arcus and AstraZeneca's TIGIT data. The episode concluded with additional data readouts, including mixed results from Alector and GSK's dementia drug, and Moderna's CMV mRNA vaccine results. *This episode aired on October 24, 2025.

“It wasn't a profession, it was a way of life,” observes internationally respected psychiatrist Dr. Nasser Loza, reflecting on a century-long family legacy in mental health care that began when his grandfather founded The Behman Hospital in Cairo. In this candid Raise the Line conversation with host Michael Carrese, Dr. Loza traces the transformation of psychiatry he's witnessed in his long career as increases in classifications, payment bureaucracy, reliance on pharmaceuticals, and technological disruption have each left their mark. The cumulative costs associated with these changes have, he laments, pushed care out of reach for many and hindered the human connection that is key to the discipline. He describes his prescription for countering these trends as a focus on effective and modest aims. “Rather than saying, come and see me in therapy for five years and I will make a better person out of you, I think focusing on symptom-targeted help is going to be what is needed.”  In this wide-ranging interview, you'll also learn about progress on advancing the rights of mental health patients and lowering stigmas, how to manage the rise of online therapy and use of AI chatbots, and the importance of empathy and transparency in mental health counseling. Don't miss this valuable perspective on a critically important dimension of healthcare that's informed by decades of experience as a clinician, government official and global advocate. Mentioned in this episode:The Behman HospitalMaadi Psychology Center If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/podcast

La educación moderna parece haberse descarrilado. Muchos de nosotros éramos al menos algo conscientes de las opiniones políticas de izquierda sobre el Complejo Industrial Educativo. Cuando se impuso la cuarentena en todo el mundo, los padres comenzaron a darse cuenta lo que sus hijos estaban aprendiendo.

Unredacted government emails obtained by Senator Ron Johnson show that health officials identified a myocarditis risk from mRNA vaccines months before informing the public. While Pfizer and Moderna were quietly notified, Americans were not. Jefferey Jaxen breaks down the evidence and new studies showing how mRNA and spike proteins affect heart tissue. Del Bigtree calls it a defining moment for accountability in public health.Become a supporter of this podcast: https://www.spreaker.com/podcast/the-highwire-with-del-bigtree--3620606/support.

“When I was in medical school, no one had even heard of mitochondrial disease. Today, every student who graduates here knows what it is and has seen a patient with it,” says Dr. Mary Kay Koenig, director of the Center for the Treatment of Pediatric Neurodegenerative Disease at UTHealth Houston McGovern Medical School. That remarkable change in awareness has been accompanied by advances in genetic sequencing, the development of clinical guidelines, and the emergence of potential treatments in some forms of mitochondrial disease. In fact, Dr. Koenig's multidisciplinary team at UTHealth's Mitochondrial Center of Excellence has been a key player in clinical trials that may yield the first FDA-approved treatments for it. As you'll learn in this Year of the Zebra conversation with host Michael Carrese, her work in neurodegenerative diseases also includes tuberous sclerosis, where advanced therapies have replaced the need for repeated surgeries, and Leigh Syndrome, which has seen improvements in diagnoses and supportive therapies leading to better quality of life for patients.  Tune in as Dr. Koenig reflects on an era of progress in the space, the rewards of balancing research, teaching and patient care, and the need for more clinicians to center listening, humility and honesty in their approach to caring for rare disease patients and their  families.Mentioned in this episode:Mitochondrial Center of ExcellenceCenter for the Treatment of Pediatric Neurodegenerative Disease If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/podcast

Más de dos mil mexicanos detenidos en EU desde el inicio de Trump  Beca Universal Rita Cetina llegará a todas las primarias públicas en 2026Tormenta tropical Melissa se forma en el AtlánticoMás información en nuestro podcast

In der heutigen Folge sprechen die Finanzjournalisten Anja Ettel und Lea Oetjen über Rebound beim Bitcoin, Rückenwind für Rüstungswerte und einen Dax-Klassiker, der mit radikalem Kurswechsel wieder richtig abheben will. Außerdem geht es um Rheinmetall, Hensoldt, Renk, Amazon, Robinhood, United Airlines, AirFrance-KLM, Reddit, Strategy, Moderna, Thyssenkrupp, Siemens, Siemens Healthineers, Continental, Vitesco, Telefónica, 1&1, United Internet, Ryanair, Lufthansa, iShares STOXX Europe 600 Travel & Leisure UCITS ETF (WKN: A0H08S0), Ether, Solana und Avalanche. Wir freuen uns an Feedback über aaa@welt.de. Noch mehr "Alles auf Aktien" findet Ihr bei WELTplus und Apple Podcasts – inklusive aller Artikel der Hosts und AAA-Newsletter.[ Hier bei WELT.](https://www.welt.de/podcasts/alles-auf-aktien/plus247399208/Boersen-Podcast-AAA-Bonus-Folgen-Jede-Woche-noch-mehr-Antworten-auf-Eure-Boersen-Fragen.html.) [Hier] (https://open.spotify.com/playlist/6zxjyJpTMunyYCY6F7vHK1?si=8f6cTnkEQnmSrlMU8Vo6uQ) findest Du die Samstagsfolgen Klassiker-Playlist auf Spotify! Disclaimer: Die im Podcast besprochenen Aktien und Fonds stellen keine spezifischen Kauf- oder Anlage-Empfehlungen dar. Die Moderatoren und der Verlag haften nicht für etwaige Verluste, die aufgrund der Umsetzung der Gedanken oder Ideen entstehen. Hörtipps: Für alle, die noch mehr wissen wollen: Holger Zschäpitz können Sie jede Woche im Finanz- und Wirtschaftspodcast "Deffner&Zschäpitz" hören. +++ Werbung +++ Du möchtest mehr über unsere Werbepartner erfahren? [**Hier findest du alle Infos & Rabatte!**](https://linktr.ee/alles_auf_aktien) Impressum: https://www.welt.de/services/article7893735/Impressum.html Datenschutz: https://www.welt.de/services/article157550705/Datenschutzerklaerung-WELT-DIGITAL.html

För femhundra år sedan reste sig bönderna i södra Tyskland mot orättvisorna. De skrev sina krav i tolv artiklar – krav på rättvisa, självstyre och rätten att leva som fria människor på sin egen jord.I det här avsnittet samtalar Dan Eriksson och Magnus Söderman om bondeupprorets idéarv och hur samma frihetslängtan lever vidare i Det fria Sverige i dag. Vad betyder det att vara fri i ett land där staten trängt in i varje vrå? Hur kan vi – likt bönderna 1525 – återta ansvar, mark och gemenskap utan våld, men med vilja, disciplin och organisation?Samtalet rör sig från Reformationen och Västgötalagen till dagens Sverige, från Martin Luther till Svenskarnas hus. Vi talar om moraliskt självstyre, rätten att välja och vräka, och om varför varje fri svensk måste börja där han står: i sin by, sitt kvarter, sin familj.Videoversion: https://www.youtube.com/watch?v=IluY1UmC1As

Anna Wood, Editor at Startups Magazine, speaks to Jenny Gardner, Director of Development at ARC - Advanced Research Clusters, all about its work in creating inclusive and flexible workspaces for the science and innovation clusters, Moderna's new manufacturing facility at its Harwell campus, and winning Workspace of the Year award at the Hustle Awards 2025. 

“Giving learners options gives them a better learning experience. It's more holistic and more comprehensive,” says Sean Moloney, CEO and founder of EmbodyXR, an extended reality platform focused on the use of immersive technologies in medical education. In this eye-opening Raise the Line conversation, Moloney explains how AI-powered extended reality (XR) --which integrates augmented, virtual, and simulation-based environments -- allows learners to interact with patients, explore multiple diagnostic choices, and experience varied outcomes based on their decisions. The result, he notes, is not only stronger engagement in learning, but a measurable improvement in understanding. Despite these gains, Moloney is quick to point out that he sees these technologies as complements to traditional training, not substitutes for it. “We'll never replace in-person teaching,” he says, “but we can make learners even better.” Beyond training future clinicians, the EmbodyXR platform is also offering new modes of patient and caregiver education, such as augmented reality guidance for using medical devices at home. Join host Lindsey Smith as she explores how EmbodyXR achieves and maintains clinical accuracy, the connectivity it offers between headsets, personal computers and mobile devices, and other capabilities that are shaping the future of how healthcare professionals and patients will learn. Mentioned in this episode:EmbodyXR If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/podcast

A Magia e Ocultismo do século XX foi moldada por três figuras importantes: Dion Fortune, Aleister Crowley e Austin Osman Spare. Embora frequentemente estudados de forma isolada, um olhar mais atento – a partir da perspectiva da própria Dion Fortune – revela uma convergência em seus trabalhos. Juntos, eles mapearam as três principais fases da consciência, criando as correntes que definem a espiritualidade esotérica até hoje.Entenda as artes ocultas de maneira objetiva e descompromissada, pelos olhos de Andrei Fernandes, Livia Andrade, Vinicius Ferreira, Marcos Keller e Carol BlackPhilipeta que se encontram na mesa redonda da magia contemporânea.PRÉ-VENDA A CABALA MÍSTICA - DION FORTUNE (GARANTA JÁ!)A Jornada do Louco: os 22 arcanos maiores do Tarô

El alcalde de Bogotá, Carlos Fernando Galán habló en 6AM de los proyectos de infraestructura que hay en estos momentos en la capital

Vacuna de Moderna se incorpora a la campaña nacional contra Covid-19 Aseguran predio con precursores químicos en CuliacánPutin ratifica acuerdo militar con CubaMás información en nuestro podcast

Why has America struggled so much to effectively manage the opioid use crisis? One of the answers, as you'll learn in this eye-opening episode of Raise the Line, is rooted in laws and attitudes from the early 20th century that removed addiction from the realm of medicine and defined it as a moral failing.  “The federal Harrison Act of 1914 forbade any physician from prescribing opioids to people with addiction, so it became more the purview of law enforcement or behavioral health or religion,” says Dr. Melody Glenn, who regularly confronts the consequences of this history during shifts in the emergency department at Banner-University Medical Center in Tucson, Arizona. And as Glenn explains to host Caleb Furnas, the resulting stigma associated with addiction has extended to the treatments for it as well, especially methadone, despite its effectiveness. Drawing on her dual expertise in emergency and addiction medicine, Glenn dispels misconceptions that medication-assisted treatment merely replaces one addiction with another, and emphasizes that harm reduction is critical to saving lives. Her desire to break prevailing stigmas led her to discover the story of Dr. Marie Nyswander, who pioneered methadone maintenance therapy in the 1960s and is featured in Dr. Glenn's new book, Mother of Methadone: A Doctor's Quest, a Forgotten History, and a Modern-Day Crisis. You'll leave this instructive interview understanding the roots of our flawed approach to addiction treatment, meeting an overlooked pioneer in the field, and admiring a devoted and compassionate physician who is following in her footsteps.  Mentioned in this episode:Banner-University Medical CenterMother of Methadone book If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/podcast

Paypal: https://www.paypal.com/paypalme/editorialtpv El día de hoy hablaremos sobre el capítulo 23 del libro The Oxford Handbook of the Protestant Reformations, titulado “Education in the Reformation” por Charlotte Methuen. Ver aquí: https://global.oup.com/academic/product/the-oxford-handbook-of-the-protestant-reformations-9780199646920?cc=gb&lang=en& . ¿Qué pasa cuando un monje convierte la escolarización en asunto de Estado? En 1524, Lutero escribió a los concejos alemanes pidiéndoles fundar y sostener escuelas públicas: niños y niñas a clase una o dos horas al día, y los más dotados encaminados al ministerio o la docencia. El objetivo no era solo alfabetizar, sino forjar “ciudadanos piadosos y útiles”. Con Melanchthon como praeceptor Germaniae, ciudades y principados promulgaron Schulordnungen que estandarizaron currículos (alemán y latín), horarios y disciplina, mientras la imprenta multiplicaba catecismos y gramáticas. Para financiar el cambio, muchos conventos se transformaron en escuelas y becas de élite (Klosterschulen de Württemberg), con días marcados por oración, canto y seis horas de estudio. La realidad, sin embargo, fue heterogénea: resistencia rural, educación femenina irregular, sacristanes enseñando con recursos mínimos. A la par, la respuesta católica profesionalizó la enseñanza (Jesuitas) y abrió vías para niñas (Ursulinas). Y en el siglo XVII, Comenius diseñó un sistema por etapas con manuales visuales para aprender “todas las cosas a todos”. Resultado: la escuela moderna nace de un proyecto confesional que buscó eruditio et pietas—conocimiento y carácter—y terminó moldeando la vida cotidiana de Europa.  Siguenos: - Web: https://teologiaparavivir.com/ - Blog: https://semperreformandaperu.org/ - Facebook: https://www.facebook.com/teologiaparavivir/ - Instagram: https://www.instagram.com/teologiaparavivir/ - Youtube: https://www.instagram.com/teologiaparavivir/

According to a 2024 World Health Organization study, over the last 50 years vaccines have saved over 154 million lives worldwide from over 20 life threatening diseases. As vaccines are facing skepticism, we are here to cut through the noise and lay out the facts as to why staying up-to-date on vaccinations is especially important for kidney patients. This episode is supported by Moderna.  In today's episode we heard from:  Mary Baliker has been a dedicated healthcare advocate for the past 40 years, and is involved in several kidney initiatives regionally, nationally and globally. Mary was diagnosed with a rare kidney disease at the age of nine and since then has undergone hemodialysis and received four kidney transplants. As a result of this life-long journey, Mary cherishes her life and possesses a strong desire to help improve the healthcare experience, health outcomes and quality of life for patients with kidney disease. In addition to publishing multiple peer reviewed articles related to the kidney patient experience, Mary is the author of Maria Never Gives Up, a story written to help children and families facing chronic illnesses. Her book is distributed across transplant and dialysis centers nationwide and is available for purchase online William Werbel, MD, PhD is a transplant infectious diseases physician and scientist at Johns Hopkins focused on optimizing protection against infections in immunocompromised persons. He completed clinical and research fellowship in infectious diseases at Johns Hopkins following MD training at the University of Michigan and internal medicine residency and chief residency at the Northwestern Feinberg School of Medicine. He is the current Associate Director for Epidemiology and Quantitative Sciences in the Johns Hopkins Transplant Research Center and principal investigator of the national Emerging Pathogens of Concern in Immunocompromised Persons (EPOC) cohort study. He receives NIH funding to study the landscape of infections in transplant recipients and evaluate the real-world impact of vaccination using a combination of epidemiological and laboratory approaches. Additional Resources: Vaccines for CKD Patients Vaccine Integrity Project IDSA Immunization Resources Emerging Pathogens of Concern in Immunocompromised Persons (EPOC) Study   Do you have comments, questions, or suggestions? Email us at NKFpodcast@kidney.org. Also, make sure to rate and review us wherever you listen to podcasts.

Dr. K discusses COVID for fall 2025, including the updated vaccine options (including Moderna's mNexspike), and the latest CDC guidelines. Plus, key reminders on this year's flu and RSV shots and practical tips for staying healthier this winter.

“We don't view a person with chronic pain as someone who has a chronic illness and the effect of that is we can't follow patients continuously over prolonged periods of time,” says Dr. Jacob Hascalovici, a neurologist and pain specialist based in New York City.  In co-founding Bliss Health, Dr. Jacob, as he is known, has set out to create a continuous care model for chronic pain treatment that matches the approach taken for patients with diabetes or high blood pressure. The Bliss Health formula includes an initial meeting with a physician that produces a care plan; remote therapeutic monitoring on an ongoing basis; and a monthly meeting with a nurse to review data and determine next steps, including additional appointments with physicians as needed.  All of this occurs via a digital platform which provides a welcome option for patients with mobility issues and can fill gaps in access to specialists, especially in rural areas. Dr. Jacob is also hoping to make chronic pain patents feel respected, which is not always the case in their encounters with the healthcare system. “Because pain is not something that can be seen or measured, oftentimes patients feel marginalized, dismissed and disempowered by providers.” Join Raise the Line host Lindsey Smith for a valuable conversation that also touches on policy changes that could strengthen telemedicine, and has details on the first non-opioid based pain medication to receive FDA approval in over 20 years.Mentioned in this episode:Bliss Health If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/podcast

Le double aveugle est une méthode utilisée surtout dans la recherche scientifique et médicale pour tester si un traitement ou une hypothèse fonctionne vraiment.Voici l'idée : quand on veut comparer un médicament à un placebo (une pilule sans effet), il faut éviter que les résultats soient influencés par des biais humains. Ces biais peuvent venir à la fois des patients et des chercheurs.Côté patients : si une personne sait qu'elle reçoit le “vrai” médicament, elle peut inconsciemment se sentir mieux, simplement parce qu'elle croit à son efficacité. C'est l'effet placebo. À l'inverse, si elle sait qu'elle a le placebo, elle peut se décourager et rapporter moins d'amélioration.Côté chercheurs : si le médecin ou l'expérimentateur sait qui reçoit le vrai traitement, il peut — même sans le vouloir — influencer son observation, par exemple en interprétant plus positivement les symptômes.Le double aveugle supprime ces biais en cachant l'information aux deux parties :Les patients ne savent pas s'ils prennent le traitement ou le placebo.Les chercheurs qui interagissent avec eux ou évaluent les résultats ne le savent pas non plus.Seul un tiers neutre (par exemple, un comité indépendant ou un logiciel qui distribue au hasard les traitements) détient la clé du code, révélée seulement à la fin de l'étude.Grâce à ce procédé, on peut comparer les résultats des deux groupes et conclure de manière beaucoup plus fiable si le médicament est vraiment efficace ou si l'amélioration est due à d'autres facteurs (placebo, hasard, biais de perception…).C'est une méthode exigeante, mais elle est considérée comme le “gold standard” en recherche clinique, c'est-à-dire la référence la plus fiable pour prouver l'efficacité d'un traitement.Exemple: les essais cliniques des vaccins contre la Covid-19Quand Pfizer-BioNTech ou Moderna ont testé leurs vaccins en 2020, les participants étaient répartis en deux groupes : certains recevaient le vrai vaccin, d'autres une simple injection saline (placebo). Ni les volontaires ni les médecins qui suivaient les symptômes ne savaient qui avait quoi. Ce n'est qu'après l'analyse statistique que les chercheurs ont “levé l'aveugle” et pu comparer les résultats, montrant une efficacité de plus de 90 % pour les premiers vaccins. Hébergé par Acast. Visitez acast.com/privacy pour plus d'informations.

In recent months, public health advocates in the United States have raised concerns about proposed changes to vaccine policy, cuts to food assistance programs, rollbacks of environmental protections and reductions in public health staffing. Chief among them has been Dr. Georges Benjamin who, as executive director of the American Public Health Association (APHA) since 2002, has led national efforts to create a healthier America. Raise the Line host Lindsey Smith recently sat down with Dr. Benjamin to understand more about the current state of public health and explore the path forward, and learned that a top priority for APHA is battling the misinformation that Dr. Benjamin believes is fueling support for many of these changes. “The challenge we have right now is that as a society, we've gone into our little corners and live in our own ecosystems. More people are getting their information from a single source and they're not validating that information to make sure that it's true.” Tune into this thoughtful and timely conversation to hear Dr. Benjamin's advice for curbing the spread of misinformation, how APHA is trying to help people understand the value of public health initiatives, and what the U.S. can learn from other countries about improving public health. Mentioned in this episode:American Public Health Association If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/podcast

Since mRNA technology was deployed widely in the COVID-19 vaccines, developers have rapidly accelerated research into more mRNA products. Moderna alone has more than two dozen mRNA products in development.But is the mRNA platform really the revolutionary breakthrough that its champions claim?Since early 2021, Cole has been at the forefront of alerting the public to an unusual spike in cancer diagnoses following the widespread adoption of the COVID-19 genetic vaccines.In this episode, Cole explains the risks he sees with mRNA technology and how he sees things shaking out at the National Institutes of Health and the Centers for Disease Control and Prevention in the coming months and years.Views expressed in this video are opinions of the host and the guest, and do not necessarily reflect the views of The Epoch Times.